ID   M-17
AC   CVCL_D028
DR   cancercelllines; CVCL_D028
DR   Cosmic; 2163788
DR   ESTDAB; ESTDAB-039
DR   Wikidata; Q54903383
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-039
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 10,13
ST   FGA: 24
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
RX   PubMed=23851445; DOI=10.1158/1541-7786.MCR-13-0006;
RA   Dahl C., Christensen C., Jonsson G., Lorentzen A., Skjodt M.L.,
RA   Borg A., Pawelec G., Guldberg P.;
RT   "Mutual exclusivity analysis of genetic and epigenetic drivers in
RT   melanoma identifies a link between p14 ARF and RARbeta signaling.";
RL   Mol. Cancer Res. 11:1166-1178(2013).
//